Placeholder Banner

Comments to FDA on the Agency’s Information Technology Strategy

October 30, 2023

BIO and PhRMA submitted joint comments on the U.S. Food and Drug Administration’s Information Technology Strategy (Docket No. FDA-2023-N-3636)

Download Full Comments Below
FINAL_PhRMA BIO Comments_FDA IT Strategy_2023-10-30
Discover More
Following the FDA Workshop to Enhance Clinical Study Diversity on November 29-30, 2023, BIO submits specific comments per the request for information (FDA-2023-N-2462).
In response to the request for information and comments, BIO submitted general comments and recommended edits (FDA-2017-D-6530)
In response to the request for information and comments, BIO submitted general comments and recommended edits (FDA-2023-D-2318)